Capital Research Global Investors Medtronic PLC Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Medtronic PLC stock. As of the latest transaction made, Capital Research Global Investors holds 36,359,462 shares of MDT stock, worth $3.44 Billion. This represents 0.66% of its overall portfolio holdings.
Number of Shares
36,359,462
Previous 41,567,616
12.53%
Holding current value
$3.44 Billion
Previous $3.74 Billion
15.15%
% of portfolio
0.66%
Previous 0.85%
Shares
32 transactions
Others Institutions Holding MDT
# of Institutions
2,449Shares Held
1.07BCall Options Held
10.9MPut Options Held
9.19M-
Vanguard Group Inc Valley Forge, PA127MShares$12 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.6 Billion0.2% of portfolio
-
State Street Corp Boston, MA59.8MShares$5.66 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY37.6MShares$3.56 Billion0.27% of portfolio
-
Geode Capital Management, LLC Boston, MA28.2MShares$2.67 Billion0.18% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $126B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...